Aquestive Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AQST Nasdaq 2834 https://aquestive.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aquestive Therapeutics Inc

Aquestive Therapeutics Announces CEO Transition - May 17th, 2022 8:01 pm
When Will Aquestive Therapeutics, Inc. (NASDAQ:AQST) Become Profitable? - May 14th, 2022 12:27 pm
Aquestive Therapeutics to Participate in H.C. Wainwright Global Investment Conference - May 10th, 2022 12:00 pm
Aquestive Therapeutics, Inc. (AQST) Q1 2022 Earnings Call Transcript - May 4th, 2022 6:30 pm
Aquestive Therapeutics (AQST) Reports Q1 Loss, Tops Revenue Estimates - May 3rd, 2022 10:55 pm
Aquestive Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update - May 3rd, 2022 9:41 pm
Aquestive Therapeutics to Report First Quarter 2022 Financial Results and Recent Business Highlights on May 3 and Host Conference Call on May 4 at 8:00 a.m. ET - Apr 18th, 2022 12:00 pm
Aquestive Therapeutics Announces Common Stock Purchase Agreement for up to $40 Million with Lincoln Park Capital - Apr 13th, 2022 12:00 pm
Aquestive Therapeutics Reports Positive Topline Data from Part 2 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film - Apr 12th, 2022 12:00 pm
Aquestive's AQST-109 Receives Fast Track Tag For Allergic Reactions - Mar 17th, 2022 3:17 pm
Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-109 for Emergency Treatment of Allergic Reactions Including Anaphylaxis - Mar 17th, 2022 12:00 pm
Aquestive Therapeutics, Inc. (AQST) Q4 2021 Earnings Call Transcript - Mar 9th, 2022 10:30 pm
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates - Mar 8th, 2022 11:15 pm
Aquestive Therapeutics Reports Full Year 2021 Results Exceeding Revenue and EBITDA Guidance - Mar 8th, 2022 9:56 pm
Aquestive Therapeutics and Haisco Pharmaceutical Group Enter Licensing and Supply Agreement for Riluzole Oral Film for ALS Treatment in China - Mar 3rd, 2022 1:00 pm
What Is The Ownership Structure Like For Aquestive Therapeutics, Inc. (NASDAQ:AQST)? - Mar 2nd, 2022 9:53 am
Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates - Mar 1st, 2022 10:45 pm
Aquestive Therapeutics Presented Positive Topline Phase 1 Results for AQST-109 Epinephrine Oral Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting - Mar 1st, 2022 1:33 am
Aquestive Highlights Early Data From Allergy Treatment Candidate AQST-109 Study - Feb 25th, 2022 3:48 pm
ImmunoGen (IMGN) Reports Q4 Loss, Tops Revenue Estimates - Feb 25th, 2022 12:45 pm